Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$277,672,632
Company Info
- Founders
- Josh Mandel-Brehm
- Company Description
- Camp4 is developing a novel approach to upregulate the expression of genes using regulatory RNA to create treatments for hundreds of diseases caused by faulty gene expression. CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
- Market
- Healthcare & Wellness
- Coinvestors
- 5AM Ventures,The Kraft Group,Patient Square Capital,Northpond Ventures,Polaris,Andreessen Horowitz
Links